Clinical trials
Terminated Myeloproliferative Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ariad Pharmaceuticals | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| CTI BioPharma | 1 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
| Kiadis Pharma | 1 |
| Martin, Paul | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 11 |
| Primary Myelofibrosis | 5 |
| Hematologic Diseases | 4 |
| Polycythemia Vera | 4 |
| Bone Marrow Diseases | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Multiple Myeloma | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.